Commentary: Until we take it seriously, the status quo of postoperative atrial fibrillation management will prevail

J Thorac Cardiovasc Surg. 2023 Jan;165(1):104-105. doi: 10.1016/j.jtcvs.2021.04.034. Epub 2021 Apr 20.

Authors

Grace Lee¹, Derrick Y Tam², Stephen E Fremes³

Affiliations

¹ Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
² Division of Cardiac Surgery, Department of Surgery, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
³ Division of Cardiac Surgery, Department of Surgery, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address: stephen.fremes@sunnybrook.ca.

PMID: 33985802
DOI: 10.1016/j.jtcvs.2021.04.034

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants
Atrial Appendage* / surgery
Atrial Fibrillation* / diagnosis
Atrial Fibrillation* / etiology
Atrial Fibrillation* / surgery
Humans
Postoperative Complications / etiology
Postoperative Complications / therapy

Substances

Anticoagulants